For instance, Durkin and colleagues demonstrated for the first time the ability of the demethylating agent decitabine to promote the differentiation of tumour-infiltrated CD11b+ cells into mature F4/80/CD11c/MHC class II-positive APCs [88]. The gene discussed is ITGAM; the disease is neoplasm.